Graça Varzim et al.
ORL; journal for oto-rhino-laryngology and its related specialties, 64(3), 206-212 (2002-05-31)
Our aim was to examine the role of NAT1 and NAT2 polymorphisms in human larynx cancer susceptibility. Genotype tests for NAT1 alleles *4, *10 and *11, and NAT2 alleles *4, *5, *6A and *7A, using PCR-RFLP analysis, were performed in